Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Gamma Butyrolactone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Rh-catalyzed route for high-purity gamma-butyrolactone derivatives with superior enantioselectivity and scalable manufacturing capabilities for global pharma supply chains.
Patent CN101250171A details a chiral phosphine-catalyzed method for gamma-butyrolactones, offering high ee values and yield for pharmaceutical intermediate manufacturing.
Novel biomass route for GBL production offering cost reduction and supply chain reliability for fine chemical intermediate manufacturing.
Patent CN114213367A details a novel nickel-catalyzed route to gamma-butyrolactone, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN117701649B reveals enzymatic DKR for Brivaracetam intermediates. Achieve 99% ee and reduced costs. Reliable pharmaceutical intermediate supplier for scale-up.
Patent CN101768141A details a safer solvent-free synthesis route. Achieve high purity and reduced environmental impact for pharmaceutical intermediate supply chains.
Novel gamma-butyrolactone route for 3-hydroxymethyl tetrahydrofuran. High yield, low cost agrochemical intermediate manufacturing process suitable for industrial scale-up.
Novel liquid sodium methoxide process boosts yield to 96%, enhancing safety and supply chain reliability for pharmaceutical intermediates.
Patent CN104250236A details efficient CuH catalyzed lactone synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Advanced Sharpless epoxidation process for (S)-beta-hydroxy-gamma-butyrolactone. Delivers high enantiomeric excess and cost-effective supply chain solutions for pharmaceutical manufacturing.
Patent CN117586211B discloses a copper-catalyzed method for beta-ester-gamma-butyrolactone offering high selectivity and cost-effective supply chain solutions.
Novel synthesis route for gamma-butyrolactone dimer anticancer compounds offers high purity and scalable manufacturing for pharmaceutical intermediates supply chains.
Patent CN112759566B details a safer, high-yield (>96%) synthesis of ABL using liquid sodium methoxide, offering significant supply chain and cost advantages for pharmaceutical manufacturers.
Patent CN100503590C details a novel Rh-catalyzed hydrogenation of L-malic acid diester. This method offers high optical purity and lower pressure conditions for efficient API intermediate manufacturing.
Patent CN103387556A details a safer synthetic route for alpha-acetyl-gamma-butyrolactone, eliminating hazardous reagents while achieving yields over 85%.
Patent CN111635437B reveals a novel palladium catalyst enabling mild, one-pot synthesis of alpha-methylene-gamma-butyrolactones, offering significant cost reduction in fine chemical manufacturing.
Novel copper-catalyzed [3+2] cycloaddition for high-purity alpha-amino-gamma-butyrolactones. Offers cost reduction in pharma intermediate manufacturing with scalable protocols.
Advanced synthesis of alpha-acetyl-gamma-butyrolactone via optimized Claisen condensation. Delivers 99.5% purity for Vitamin B1 and agrochemical manufacturing with reduced costs.
Novel Pd-catalyzed route for alpha-methylene-gamma-butyrolactone derivatives. Mild conditions, high functional group tolerance, scalable supply chain solutions for global pharmaceutical manufacturing partners.
Patent CN109553595A reveals mild chiral gamma-butyrolactone synthesis. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.